Globally, we defined 538 and 722 SEs in Karpas-299 (systemic ALCL, ALK+) and Mac-1 (derived from cutaneous T-NHL later progressing to ALCL) cell lines (Fig. 1a, b), respectively. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.